Publications:

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.

Hepatology (Baltimore, Md.)

Welzel, Tania Mara TM; Morgan, Timothy R TR; Bonkovsky, Herbert L HL; Naishadham, Deepa D; Pfeiffer, Ruth M RM; Wright, Elizabeth C EC; Hutchinson, Amy A AA; Crenshaw, Andrew T AT; Bashirova, Arman A; Carrington, Mary M; Dotrang, Myhanh M; Sterling, Richard K RK; Lindsay, Karen L KL; Fontana, Robert J RJ; Lee, William M WM; Di Bisceglie, Adrian M AM; Ghany, Marc G MG; Gretch, David R DR; Chanock, Stephen J SJ; Chung, Raymond T RT; O'Brien, Thomas R TR; ,

Publication Date: 2009-06

Variant appearance in text: rs2307483

PubMed Link: 19434718

Variant Present in the following documents:

• Main text

View BVdb publication page

Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease.

Vaccine

Belsher, Jon L JL; Gay, Peter P; Brinton, Margo M; DellaValla, Joseph J; Ridenour, Robert R; Lanciotti, Robert R; Perelygin, Andrey A; Zaki, Sherif S; Paddock, Christopher C; Querec, Troy T; Zhu, Tuofu T; Pulendran, Bali B; Eidex, Rachel B RB; Hayes, Edward E

Publication Date: 2007-12-05

Variant appearance in text: rs2307483

PubMed Link: 18023511

Variant Present in the following documents:

• main.pdf

View BVdb publication page